Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, March 26, 2013

Etanercept(Enbrel) and IBMs' Watson

This is from a technology site so take what they are saying with a grain of salt. Video training on how to apply it. Still seems more like a puff piece.
Patented by Amgen.
http://www.hpcwire.com/hpcwire/2013-03-26/ibm_s_watson_making_diagnosis_and_treatment_recommendations.html
According to an article in the March 2013 edition of Atlantic magazine titled “The Robot Will See You Now," IBM’s super computer Watson has teamed up with Memorial Sloan/Kettering Hospital to make diagnosis and treatment recommendations. IBM Watson has been programmed with 600,000 pieces of medical evidence from over two million pages of medical text as well as the entire English version of Wikipedia all stored in 15 terabytes of RAM (15 trillion bytes of memory). This is roughly equivalent to the information contained on a bookshelf that is 19 miles long.

“Computer-driven, evidence-based advice like that provided by IBM’s Watson gives validity to the off label use of prescription drugs” states Rolando Rodriguez, M.D., Neurosurgeon at Neurological Wellness Center. “The perispinal administration of the drug etanercept (Enbrel) to patients diagnosed with Alzheimer’s, stroke or traumatic brain injury (TBI) has the potential to enable a significant recovery in memory, mood, speech and physical function,” stated Dr. Rodriguez. “Doctors and nurses are drowning in information with new research popping up daily. They often don’t know what to do and are guessing as well as they can,” said Samuel Nussbaum, WellPoint’s Chief Medical Officer.

A general consensus is emerging among healthcare professionals that to effectively address the many problems in the present healthcare system in America will require a fundamental redesign, a transformation in which existing modalities are replaced by new care delivery paradigms. The expansion of computer medical decision support systems like that provided by IBM's Watson has emerged as one of the areas where there is broad support among the medical community. The proliferation of biomedical information will continue to accelerate taxing the cognitive abilities of physicians as they struggle with the weight of new research findings, clinical guidelines, and recommendations of best practices. Computerized medical decision support systems certainly have the potential to produce better outcomes, increase productivity, lower costs and reduce the occurrence of adverse events.

Perispinal injections of the drug Enbrel are an excellent example. “The medical research is clear: a single injection has the potential to produce a life-changing recovery in persons afflicted with stroke or traumatic brain injury with little to no risk to health, yet the procedure is only slowly starting to gain traction with mainstream medicine,” states Dr. Rodriguez. IBM’s Watson has the potential to be a major game changer in the field of medicine. When physicians’ diagnoses and treatment decisions are evaluated with computer-assisted 20/20 hindsight WellPoint’s Samuel Nussbaum said that “health care professionals make accurate treatment decisions in lung cancer cases only 50% of the time.” “The dictates of a capitalistic healthcare system preclude a drug like Enbrel from ever gaining FDA approval for the treatment of stroke or TBI. The estimated cost for repurposing Enbrel for treating stroke and TBI is $100 million. Considering just one to eight doses are required for the complete treatment, I can be confident this drug will never be approved for stroke or TBI” said Augusto Ramirez, M.D., of Neurological Wellness Center. Neurological Wellness Center offers a complete two-hour course on Alzheimer's treatment, stroke treatment and traumatic brain injury treatment covering all aspects of perispinal injection technique at their center in Managua Nicaragua.

For many, flying to Managua Nicaragua to receive this personalized training is an enormous expense and inconvenience. To overcome this problem, Neurological Wellness Center, under the direction of Augusto Ramirez, M.D., created Perispinal Enbrel Step-By-Step Instructional Video and accompanying e-book.

Neurological Wellness Center’s perispinal Enbrel is profoundly effective as an Alzheimer’s treatment, stroke treatment and TBI treatment. The complete treatment recommendation: for stroke is one 25mg injection of Enbrel every four days for a total of four doses over 16 days; for TBI is one 25mg injection of Enbrel every four days for a total of eight doses. This compares with Amgen/Pfizer’s FDA-approved dose schedule for moderate plaque psoriasis of 50mg twice weekly for three months followed by 50mg weekly for life. The Neurological Wellness Center’s maximum recommended dose for Alzheimer’s disease is 25mg/week for life.

The drug Enbrel is available now. Enbrel received FDA approval in 1998. Its safety profile is well understood. For Enbrel to effectively treat Alzheimer’s, stroke and TBI, it must be administered to the back of the neck precisely between the cervical vertebrae C-5 and C-6. (I wouldn't allow just any doctor to inject me at this location)This perispinal injection allows Enbrel to enter the brain by lymph drainage assisted by gravity. Fortunately for the millions of people now afflicted with Alzheimer’s, stroke and TBI, a video is now available online detailing in step-by-step fashion how to administer a perispinal injection of Enbrel,” said Dr. Rolando Rodrigues.

No comments:

Post a Comment